Sign in

Healthpeak Properties, Inc. DOC

Price 21.0 USD
as of 2026-09-03
47/100
No view
Quality38
Growth32
Balance-sheet strength43
Valuation45
Momentum69
Income92

Composite 47/100; the shares have moved about 34% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Growth ranks 32/100 — a moderate mark against it.

Case for

Income ranks 92/100 — a strong point in its favour. Momentum ranks 69/100 — a moderate point in its favour.

Case against

Growth ranks 32/100 — a moderate mark against it. Quality ranks 38/100 — a moderate mark against it. Balance-sheet strength ranks 43/100 — a slight mark against it.

What the company does Healthpeak Properties (DOC) is a REIT focused on high-quality healthcare real estate for discovery and delivery, including senior housing, life science, and medical offices.

Key financials Gross margin 57.6% and net margin 8.2% sit below peer medians; ROE 3.0% and ROA 1.5% are weak. Debt/Equity 1.09 and interest coverage 2.03 signal moderate leverage risk.

Stock health Sideravia scores Quality 38.3 and Valuation 41.4, offset by Momentum 69.2 and Income 92.2. Piotroski F-Score 5/9 and RSI 41.40 suggest mixed fundamentals and neutral momentum.

Price vs fair value DOC trades at a discount of 10.00% versus the analyst mean target of 22.87. - Q2 2026 earnings call transcript highlights execution challenges (Motley Fool). - Zacks flags elevated options-implied volatility, hinting at uncertainty (Zacks).

Looking forward Forward P/E 142.86 implies high growth expectations; dividend yield 5.9% supports income appeal but payout ratio 61.8% limits reinvestment flexibility.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-03, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.